MoonLake Immunotherapeutics (MLTX) Change in Cash (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) posted quarterly Change in Cash of -$36.0 million for Q1 2026, down 139.53% year-over-year from $91.1 million in Q1 2025, and down 122.13% quarter-over-quarter from -$16.2 million in Q4 2025.
MoonLake Immunotherapeutics (MLTX) Change in Cash (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Change in Cash history runs 6 years deep, the most recent figure standing at -$36.0 million for Q1 2026.
- In Q1 2026, Change in Cash fell 139.53% year-over-year to -$36.0 million; the TTM figure through Mar 2026 stood at $26.9 million (up 114.41% YoY), while the FY2025 annual figure was $154.1 million, up 156.91% from the prior year.
- Change in Cash for Q1 2026 stood at -$36.0 million, down from -$16.2 million in the prior quarter.
- The five-year high for Change in Cash was $451.7 million in Q2 2023, with the low at -$195.2 million in Q4 2024.
- The 5-year median for Change in Cash is $7.3 million (2024), against an average of $17.1 million.
- The sharpest annual moves came in 2022 and 2023: Change in Cash tumbled 3259.8% in 2022, then surged 7928.12% in 2023.
- MoonLake Immunotherapeutics' Change in Cash stood at -$1.7 million in 2022, then soared by 7928.12% to $133.0 million in 2023, then sank by 246.79% to -$195.2 million in 2024, then surged by 91.69% to -$16.2 million in 2025, then tumbled by 122.13% to -$36.0 million in 2026.
- Business Quant data shows MLTX's Change in Cash at -$36.0 million in Q1 2026, -$16.2 million in Q4 2025, and $44.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | MoonLake Immunotherapeutics | 1.40 Bn | 864.68 Mn | - | 179.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 179.42 Mn |
| Mar 31, 2026 | -36.03 Mn |
| Dec 31, 2025 | -16.22 Mn |
| Sep 30, 2025 | 44.06 Mn |
| Jun 30, 2025 | 35.12 Mn |
| Mar 31, 2025 | 91.14 Mn |
| Dec 31, 2024 | -195.23 Mn |
| Sep 30, 2024 | 32.86 Mn |
| Jun 30, 2024 | -115.65 Mn |
| Mar 31, 2024 | 7.27 Mn |
| Dec 31, 2023 | 133.00 Mn |
| Sep 30, 2023 | -183.62 Mn |
| Jun 30, 2023 | 451.66 Mn |
| Mar 31, 2023 | 10.62 Mn |
| Dec 31, 2022 | -1.70 Mn |
| Sep 30, 2022 | -51.50 Mn |
| Jun 30, 2022 | 83.87 Mn |
| Mar 31, 2022 | 795,313.00 |
| Dec 31, 2021 | 8.04 Mn |
| Sep 30, 2021 | -1.53 Mn |